AVRO - AVROBIO: Undercovered Gene Therapy Developer With Excellent Promise
- AVROBIO is developing gene therapies for lysosomal disorders where lifelong enzyme replacement therapy is the SoC.
- Early stage data shows promise.
- If successful, it is looking at a multibillion dollar market.
For further details see:
AVROBIO: Undercovered Gene Therapy Developer With Excellent Promise